| Heavy metal poisoning: clinical presentations and pathophysiology D Ibrahim, B Froberg, A Wolf, DE Rusyniak Clinics in laboratory medicine 26 (1), 67-97, 2006 | 302 | 2006 |
| Neurologic manifestations of chronic methamphetamine abuse DE Rusyniak Psychiatric Clinics 36 (2), 261-275, 2013 | 287 | 2013 |
| Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study DE Rusyniak, MA Kirk, JD May, LW Kao, EJ Brizendine, JL Welch, ... Stroke 34 (2), 571-574, 2003 | 276 | 2003 |
| Organophosphate poisoning DE Rusyniak, KA Nañagas Seminars in neurology 24 (02), 197-204, 2004 | 165 | 2004 |
| Willingness of long‐term care staff to receive a COVID‐19 vaccine: a single state survey KT Unroe, R Evans, L Weaver, D Rusyniak, J Blackburn Journal of the American Geriatrics Society 69 (3), 593-599, 2021 | 154 | 2021 |
| Synthetic cathinones (“bath salts”) ML Banks, TJ Worst, DE Rusyniak, JE Sprague The Journal of emergency medicine 46 (5), 632-642, 2014 | 134 | 2014 |
| The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3, 4-methylenedioxymethamphetamine EM Mills, DE Rusyniak, JE Sprague Journal of molecular medicine 82, 787-799, 2004 | 112 | 2004 |
| HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures BA Bennett, DE Rusyniak, CK Hollingsworth Brain research 705 (1-2), 168-176, 1995 | 108 | 1995 |
| Toxin-induced hyperthermic syndromes DE Rusyniak, JE Sprague Medical Clinics 89 (6), 1277-1296, 2005 | 105 | 2005 |
| Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3, 4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model JE Sprague, P Moze, D Caden, DE Rusyniak, C Holmes, DS Goldstein, ... Critical care medicine 33 (6), 1311-1316, 2005 | 89 | 2005 |
| Police officers can safely and effectively administer intranasal naloxone R Fisher, D O'Donnell, B Ray, D Rusyniak Prehospital Emergency Care 20 (6), 675-680, 2016 | 83 | 2016 |
| Thallium and arsenic poisoning in a small midwestern town DE Rusyniak, RB Furbee, MA Kirk Annals of emergency medicine 39 (3), 307-311, 2002 | 79 | 2002 |
| Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse AD O'Connor, DE Rusyniak, A Bruno Medical Clinics 89 (6), 1343-1358, 2005 | 76 | 2005 |
| Heavy metal poisoning: management of intoxication and antidotes DE Rusyniak, A Arroyo, J Acciani, B Froberg, L Kao, B Furbee Molecular, Clinical and Environmental Toxicology: Volume 2: Clinical …, 2010 | 71 | 2010 |
| Attenuation of 3,4‐methylenedioxymethamphetamine (MDMA, Ecstasy)‐induced rhabdomyolysis with α1‐ plus β3‐adrenoreceptor antagonists JE Sprague, RE Brutcher, EM Mills, D Caden, DE Rusyniak British journal of pharmacology 142 (4), 667-670, 2004 | 67 | 2004 |
| Acute methylenedioxypyrovalerone toxicity BA Froberg, M Levine, MC Beuhler, BS Judge, PW Moore, ... Journal of Medical Toxicology 11, 185-194, 2015 | 61 | 2015 |
| Neuroleptic malignant syndrome and serotonin syndrome LM Tormoehlen, DE Rusyniak Handbook of clinical neurology 157, 663-675, 2018 | 57 | 2018 |
| Estimating the weight of children in Kenya: do the Broselow tape and age-based formulas measure up? DR House, E Ngetich, RC Vreeman, DE Rusyniak Annals of emergency medicine 61 (1), 1-8, 2013 | 55 | 2013 |
| UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia JE Sprague, NM Mallett, DE Rusyniak, E Mills Biochemical pharmacology 68 (7), 1339-1343, 2004 | 53 | 2004 |
| The role of mitochondrial uncoupling in 3, 4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis DE Rusyniak, SL Tandy, SK Hekmatyar, E Mills, DJ Smith, N Bansal, ... Journal of Pharmacology and Experimental Therapeutics 313 (2), 629-639, 2005 | 50 | 2005 |
